The Office of Surveillance in the US FDA’s Office of Pharmaceutical Quality has launched a program to work with drug manufacturing facilities that may be at risk of causing quality-related drug shortages, agency officials told the recent 2018 International Society for Pharmaceutical Engineering annual meeting in Philadelphia.
“It’s a voluntary program to encourage quality practices at FDA-selected manufacturers with the goal of ensuring availability of quality pharmaceuticals,”...